# Styrian Vitamin D Hypertension Trial

Study · id `cardio:ct-nct02136771` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02136771](<https://clinicaltrials.gov/study/NCT02136771>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02136771

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT02136771. Randomized; quadruple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2014-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT02136771, source copy `cardio:ctgov-nct02136771-2014-11-25`, retrieved 2026-10-26)
- Start date: 2011-06 (registry gives no type) (ClinicalTrials.gov record NCT02136771, source copy `cardio:ctgov-nct02136771-2014-11-25`, retrieved 2026-10-26)
- Primary completion: 2014-08 (actual) (ClinicalTrials.gov record NCT02136771, source copy `cardio:ctgov-nct02136771-2014-11-25`, retrieved 2026-10-26)
- Completion: 2014-08 (actual) (ClinicalTrials.gov record NCT02136771, source copy `cardio:ctgov-nct02136771-2014-11-25`, retrieved 2026-10-26)
- Countries: Austria (ClinicalTrials.gov record NCT02136771, source copy `cardio:ctgov-nct02136771-2014-11-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02136771-2014-11-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Styrian Vitamin D Hypertension Trial
- Condition: Arterial Hypertension
- Condition: Vitamin D Deficiency
- Intervention (Dietary supplement): Vitamin D3
- Intervention (Dietary supplement): Placebo
- Lead sponsor: Medical University of Graz
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Medical University of Graz (`cardio:org-medical-university-of-graz`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial (`cardio:pubmed-25801871`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial (`cardio:pubmed-27098193`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension (`cardio:pubmed-28027911`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized trial of vitamin D versus placebo supplementation on markers of systemic inflammation in hypertensive patients (`cardio:pubmed-34629245`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5c81560c647a75ffc8f3ee71443de54c069473512737bade5a56a2c6cdb45fc2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
